SEHK:2269Life Sciences
Is WuXi Biologics (SEHK:2269) Offering Value After Its Recent Share Price Recovery?
If you are wondering whether WuXi Biologics (Cayman) is attractively priced or still carrying past baggage, the key is to separate headline moves from underlying value.
The stock last closed at HK$32.74, with returns of 0.6% year to date and 32.8% over the past year, even though it is still down 27.0% over three years and 73.8% over five years.
Recent share price moves have come alongside ongoing attention on WuXi Biologics (Cayman)'s role in global biologics development and contract...